In this issue:
Utidelone + capecitabine vs capecitabine for heavily pre-treated mBC
Alpelisib + fulvestrant for PIK3CA-mutated, HR+/HER2– aBC
Efficacy of therapy by discordance of HER2 expression between primary and metastatic sites
Addition of chemo to local therapy in older women with TNBC
Olaparib for mBC and mutations in homologous recombination-related genes
MRI–guided biopsy to verify pCR after neoadjuvant chemo
Phyllodes tumours: a need for more individualised margin guidelines?
Preventing lymphoedema in women treated for breast cancer
Reproductive outcomes with vs without fertility preservation
Internal mammary and medial supraclavicular lymph node chain irradiation
Please login below to download this issue (PDF)